Abstract: The present invention relates to a pharmaceutical composition for combined administration of melatonin and prostaglandin E2 (PGE2) for the treatment of intestinal epithelial injury diseases, and it is confirmed that when intestinal epithelial organoids are treated in combination with melatonin and PGE2, the expression of revival stem cell markers increases more than when the two substances are treated alone, and therefore it can be usefully used as a composition for preventing, treating or improving intestinal epithelial injury diseases.

Abstract: Disclosed herein is an electric double layer device including a urethane potting unit (50) for filling the gap between a portion of a first terminal (21) that is exposed out of a rubber cap (40) and a first through hole (41) and the gap between a portion of a second terminal (22) that is exposed out of the rubber cap and a second through hole (42), wherein an aluminum terminal (A) constituting each of the first terminal (21) and the second terminal (22) is anodized such that an aluminum oxide film (Al) is formed on the aluminum terminal, whereby the lifespan of the electric double layer device is relatively increased.

Abstract: Disclosed herein is an electric double layer device including a urethane potting unit (50) for filling the gap between a portion of a first terminal (21) that is exposed out of a rubber cap (40) and a first through hole (41) and the gap between a portion of a second terminal (22) that is exposed out of the rubber cap and a second through hole (42), wherein an aluminum terminal (A) constituting each of the first terminal (21) and the second terminal (22) is anodized such that an aluminum oxide film (Al) is formed on the aluminum terminal, whereby the lifespan of the electric double layer device is relatively increased.